Patent Assignment
Reel/Frame 070725/0291
Nunc Pro Tunc Assignment
Recorded: 2025-04-03
Pages: 29
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2025-02-25
Assignee
HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
16 XUEFU ROAD, HIGH & NEW TECH DEVELOPMENT ZONE, NANJING, 210061, CHINA
Covered Properties
(29)
Organic Compounds
Application:
11/828,224 →
Publication:
US 2009/0118366
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
13/438,160 →
Publication:
US 2013/0040954
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
14/283,734 →
Publication:
US 2014/0256731
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
15/480,756 →
Publication:
US 2017/0266194
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/023,880 →
Publication:
US 2018/0303842
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/277,143 →
Publication:
US 2019/0175603
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/593,449 →
Publication:
US 2020/0030335
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/881,117 →
Publication:
US 2020/0281933
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/138,097 →
Publication:
US 2021/0113571
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/401,418 →
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/702,304 →
Publication:
US 2022/0218713
Injectable Pharmaceutical Formulations of Lefamulin
Application:
18/891,571 →
Publication:
US 2025/0009885
Novel Therapeutic Use of Pleuromutilins
Application:
17/919,202 →
Publication:
US 2023/0218558
Therapeutic Use of Pleuromutilins
Application:
17/919,200 →
Publication:
US 2023/0174472
Therapeutic Use of Pleuromutilins
Application:
18/837,088 →
Publication:
US 2025/0134844
Use of Pleuromutilins for the Treatment of Disorders Caused by Helicobacter Pylori
Pleuromutilin Derivatives as Antimicrobials
Pleuromutilin Derivatives Containing a Hydroxyamino- or Acyloxyaminocycloalkyl Group
Process for the Preparation of Pleuromutilins
Pleuromutilins and Process for the Preparation of Pleuromutilins
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Organic Compounds
Organic Compounds
Enantiomerically Pure Amines
Process for the Preparation of Pleuromutilins
Pleuromutilin Derivatives for Use in the Treatment of Diseases Mediated by Microbes
Injectable Pharmaceutical Formulations of Lefamulin
Purification of Pleuromutilin
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 22, 2007
From: ASCHER, GERD; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018931/0846 →
Assignment of Assignor's Interest
Mar 21, 2007
From: BERNER, HEINZ; KERBER, GABRIELE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019049/0959 →
Assignment of Assignor's Interest
Nov 15, 2007
From: MANG, ROSEMARIE; ASCHER, GERD; FERENCIC, MATHIAS; HEILMAYER, WENER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0912 →
Assignment of Assignor's Interest
Dec 18, 2007
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020268/0923 →
Change of Name
Aug 11, 2008
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021371/0769 →
Assignment of Assignor's Interest
May 15, 2009
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 022691/0682 →
Assignment of Assignor's Interest
Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest
Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Assignment of Assignor's Interest
Oct 29, 2012
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029205/0095 →
Assignment of Assignor's Interest
Apr 9, 2013
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 030177/0294 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Lien
Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Change of Name
Sep 24, 2014
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033813/0230 →
Security Interest
Sep 26, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033833/0311 →
Assignment of Assignor's Interest
Oct 13, 2014
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033934/0969 →
Assignment of Assignor's Interest
Oct 13, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033935/0048 →
Release of Security Interest
Nov 13, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037040/0320 →
Release of Security Interest
Nov 19, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037093/0308 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement.
Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Release of Security Interest
Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Release of Security Interest
Sep 29, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 039894/0473 →
Assignment of Assignor's Interest
Apr 24, 2017
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 042126/0873 →
Change of Name
Jul 18, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047958/0106 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →